Poniard Pharmceuticals/ US7324492021 /
03.02.2022 00:00:00 | Diff. - | Volumen | Geld- | Brief- | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
0.0001USD | - | 300 Umsatz: - |
-Geld Vol: - | -Brief Vol: - | 0.0001 | 0.0001 |
GlobeNewswire
22:45
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Bu...
GlobeNewswire
22:45
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
22:44
Chocxo Dark Milk Chocolate Snaps Named a Winner in Good Housekeeping’s 2024 Best Snack Awards
GlobeNewswire
22:42
Jamf Announces Launch of Secondary Offering of Common Stock by Selling Stockholders and Related Comm...
GlobeNewswire
22:36
Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:33
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against FAT Brands Inc...
GlobeNewswire
22:30
Farmers & Merchants Bancorp (FMCB) ranked #6 on Forbes Magazine’s List of “America’s Best Banks” for...
GlobeNewswire
22:30
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
GlobeNewswire
22:30
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conferen...
GlobeNewswire
22:30
STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conf...
GlobeNewswire
22:30
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
GlobeNewswire
22:30
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire
22:30
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticip...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite